CellGenix (Freiburg im Breisgau, Germany) presents the top considerations when deciding upon a T-cell medium in this new infographic.
Developing cutting-edge CAR-T therapies can be challenging enough, without the added issues from culturing cells.
In this latest infographic, CellGenix (Freiburg im Breisgau, Germany) discuss their handy tips for choosing the correct T-cell medium, to ensure that you are ready to produce and scale your T-cell therapies.
If you are interested in further discussing your T-cell medium needs, please enquire at www.cellgenix.com/products/tcm.
Have any additional questions about this story? Ask us in the comments, below.
Find out more in these top picks from the Editor:
- Introducing CellGenix T-cell medium — early onset of T-cell expansion for faster T-cell therapy manufacturing
- ‘Smart CAR-T’ immunotherapy safer and more effective in mice
- Preparing your raw materials for commercial manufacture: an interview with Bernd Leistler